Celltrion Wins Global First Approval For High-Concentration Humira Biosimilar

Yuflyma 100mg/ml Version Of Adalimumab Ready For Launch In Europe

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.